Genetic disorders of lipoprotein transport in children

Progress in Pediatric Cardiology

Volumn 17, Issue 2, 2003, Pages 123-133

  Clauss, Sarah B ^a   Kwiterovich, Peter O ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b University Lipid Clinic   (United States)

Author keywords

Apolipoproteins; Dyslipidemia; Genetics; Lipoproteins; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SITOSTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AUTOSOMAL RECESSIVE DISORDER; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; HYPOLIPOPROTEINEMIA; LIPID DIET; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCREENING; TANGIER DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0041335196     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(03)00049-3     Document Type: Article

References (67)

1. Berenson G.S., Wattigney W.A., Tracy R.E., et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necroscopy (the Bogulusa Heart study). Am J Cardiol. 70:1992;851-858.
2. Strong J.P. The natural history of coronary atherosclerosis. Am J Pathol. 40:1962;37-49.
3. Klag M.J., Ford D.E., Mead L.A., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 328:1993;313-318.
4. Clarke W.R. Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation. 58:1978;626-663.
5. National Cholesterol Education Program (NCEP). Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495-501.
6. Policy Statement. Cholesterol in childhood. Pediatrics 1998;101:141-47.
7. Cortner J.A., Coates P.M., Gallagher P.R. Prevalence and expression of familial combined hyperlipidemia in childhood. J Ped. 116:1990;514-524.
8. Goldstein J.L., Brown M.S. The cholesterol quartet. Science. 292:2001;1310-1316.
9. Kwiterovich P.O. Jr. Diagnosis and management of familial dyslipoproteinemia in children and adolescents. Pediatr Clin North Am. 37:1990;1489-1523.
10. Hobbs H.H., Brown M.S., Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1:1992;445-466.
11. Norman D., Sun X., Bourbon, et al. Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia. J Clin Invest. 104:1999;619-628.
12. Zuliani G., Arca M., Signore A., et al. Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol. 19:1999;802-809.
13. Garcia C.K., Wilund K., Arca M., et al. Autsomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 292:2001;1394-1398.
14. Arca M., Zuliani G., Wilund K., et al. Autosomal recessive hypercholesterolemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular analysis. Lancet. 359:2002;841-847.
15. Knott T.J., Wallis S.C., Powell L.M., et al. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 14:1986;7501-7503.
16. Soria L.F., Ludwig E.H., Clarke H.R., et al. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA. 86:1989;587-591.
17. Bhattacharyya A.K., Connor W.E. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 53:1974;1033-1043.
18. Miettinen T.A. Phytosterolemia, xanthomatosis, and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest. 10:1980;27-35.
19. Kwiterovich P.O. Jr., Bachorik P.S., Smith H.H., et al. Hyperapobetalipoproteinemia in two families with xanthomas and phytosterolemia. Lancet. 1:1981;466-469.
20. Bjorkhem I., Boberg M. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic bases of inherited disease, vol. 2. 7th ed. 1995;2073 McGraw-Hill, New York. Chap. 65.
21. Miettinen T.A. Phytosterolemia, xanthomatosis, and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest. 10:1980;27-35.
22. Lutjohann D., Bjorkham I., Beil V.F., von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res. 36:1995;1763.
23. Berge K.E., Tian H., Graf G.A., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290:2000;1771-1775.
24. Lu K., Lee M.-H., Hazard S., et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving Sterolin-1 and Sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 69:2001;278-290.
25. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters, ABCG5 and ABCG8, by the oxysterol receptors, LXR alpha and beta. J Biol Chem. 24:2002;18793-18800.
26. Goldstein J.L., Schrott H.G., Hazzard W.R., et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 52:1973;1544-1568.
27. Ginsberg H.N. Insulin resistance and cardiovascular disease. J Clin Invest. 106:2000;453-458.
28. Hokanson J.E., Krauss R.M., Albers J.J., et al. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 15:1995;452-459.
29. Austin M.A., Breslow J.L., Hennekens C.H., et al. Low-density lipoprotein patterns and risk of myocardial infarction. JAMA. 260:1998;1917-1921.
30. Hunt S.C., Wu L.L., Hopkins P.N., et al. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 9:1989;335-344.
31. Reaven G.M., Chen Y.D., Jeppesen J., et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 92:1993;141-145.
32. Allayee H., Krass K.L., Pajunkanta P., et al. Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia. Circ Res. 90:2002;926-931.
33. Pajukanta P., Nuotio I., Terwillinger J.D., et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet. 18:1998;369-373.
34. Pei B., Baron H., Muller-Myhsok B., et al. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families. Clin Genet. 57:2000;29-34.
35. Coon H., Myers R.H., Borecki I.B., et al. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol. 20:2000;2275-2280.
36. Aouizerat B.E., Allayee H., Cantor D.M., et al. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet. 65:1999;397-412.
37. Kwiterovich P.O. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol. 86:2000;5L-10L.
38. Brunzell J.D., Hokanson J.E. Dyslipidemia of central obesity and insulin resistance. Diabetes Care. 22:1999;C10-C13.
39. Freedman D.S., Dietz W.H., Srinivasan S.R., Berenson G.S. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 103:1999;1175-1182.
40. Aitman T.J., Glazier A.M., Wallace C.A., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 21:1999;76-83.
41. Aitman T.J., Glazier A.M., Wallace C.A., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 21:1999;76-83.
42. Pravenec M., Zidek V., Simakova M., et al. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest. 103:1999;1651-1657.
43. Arya R., Blangero J., Williams K., et al. Factors of insulin resistance syndrome - related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Americans. Diabetes. 51:2002;841-847.
44. Duggirala R., Blangero J., Almasy L., et al. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet. 66:2000;1237-1245.
45. Brunzell J.D. Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The molecular basis of inherited disease. 1989;1165 McGraw-Hill, New York.
46. Feoli-Fonseca J.C., Levy E., Godard M., et al. Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Ped. 133:1998;417-423.
47. Rouis M., Dugi K.A., Previato L., et al. Therapeutic response to medium-chain triglycerides and ω-3 fatty acids in a patient with the familial chylomicronemia syndrome. Arterioscler Thromb Vasc Biol. 17:1997;1400-1414.
48. Deeb S.S., Peng R. Structure of the human lipoprotein lipase gene. Biochemistry. 28:1989;4131-4135.
49. Wion K.L., Kirchgessner T.G., Lusis A., et al. Human lipoprotein lipase complementary DNA sequence. Science. 235:1987;1638-1641.
50. Gilbert T., Rouis M., Griglio S., et al. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of the reported mutations: 75% are clustered in exons 5 and 6. Ann Genet. 44:2001;25-32.
51. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
52. Ordovas J.M., Litwack-Klein L., Wilson P.W., et al. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res. 28:1987;371-380.
53. Xhignesse M., Lussier-Cacan S., Sing C.F., et al. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb. 11:1991;1100-1110.
54. Lambert M., Assouline L., Feoli-Fonseca J.C., et al. Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 21:2001;979-984.
55. Yanagi H., Shimakura Y., Yamanouchi Y., et al. Association of hypercholesterolemia and apolipoprotein E4 in school children. Clin Genet. 38:1990;264-269.
56. Wiegman A., Sijbrands E.J., Rodenburg J., et al. The apolipoprotein ε 4 allele confers additional risk in children with familial hypercholesterolemia. Pediat Res. 53:2003;1008-1012.
57. Yamakawa-Kobayashi K., Yanagi H., Fukayama H., et al. Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-1 gene in the population: a population based study. Hum Mol Gen. 8:1999;331-336.
58. Law S.W., Gray G., Brewer H.B. Jr., et al. Human apolipoprotein A-I and C-III genes reside in the p11-q13 region of chromosome 11. Biochem Biophys Res Commun. 118:1984;934-942.
59. Franceschini G., Sisrtori M., Gianfreceshi G., et al. Relation between the HDL apoproteins and AI isoproteins in subjects with the AI Milano abnormality. Metabolism. 30:1981;502-509.
60. Gualandri V., Orsini G.B., Cerrone A., et al. Familial associations of lipids and lipoproteins in a highly consanguineous population: the Limone sul Garda study. Metabolism. 34:1984;212-221.
61. Remaley A.T., Rust S., Rosier M., et al. Human ATP-binding cassette transporter a (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. PNAS. 96:1999;12685-12690.
62. Bodzioch M., Orso E., Klucken, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 22:1999;347-351.
63. Brooks-Wilson A., Marcil M., Clee S.M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 22:1999;336-345. Rust R., Rosier M., Funke H., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 22:1999;352-355.
64. Rust R., Rosier M., Funke H., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 22:1999;352-355.
65. Suzuki K., Kuriyama M., Saito T., et al. Plasma lipoprotein (a) levels and expression of the apolipoprotein (a) gene are dependent on the nucleotide polymorphisms in its 5″-flanking region. J Clin Invest. 99:1997;1361-1366.
66. Berg K., Dahlen G., Borresen A.L. Lp (a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin Genet. 16:1979;347-352.
67. Nowak-Gottl U., Debus O., Findeisen M., et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics. 99:(6):1997;E11.